RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly population.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 24148573)

Published in Vaccine on October 19, 2013

Authors

M J Meijboom1, K B Pouwels, W Luytjes, M J Postma, E Hak

Author Affiliations

1: Unit of PharmacoEpidemiology & PharmacoEconomics (PE(2)), Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Department of Epidemiology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.

Articles by these authors

Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A (1990) 7.68

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis (2005) 4.71

The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol (1991) 3.85

Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens. Sex Transm Infect (2001) 2.85

The primary structure and expression of the second open reading frame of the polymerase gene of the coronavirus MHV-A59; a highly conserved polymerase is expressed by an efficient ribosomal frameshifting mechanism. Nucleic Acids Res (1990) 2.71

Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. Proc Natl Acad Sci U S A (1999) 2.42

Influenza- and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J (2007) 2.27

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A (1988) 2.24

The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus. Virology (1996) 2.15

Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J Mol Biol (1987) 2.07

Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clin Exp Allergy (2014) 2.06

Attitude of Dutch hospital personnel towards influenza vaccination. Vaccine (2008) 2.02

Pharmaco-economics of blood transfusion safety: review of the available evidence. Vox Sang (2002) 1.80

The value of ProMED-mail for the Early Warning Committee in the Netherlands: more specific approach recommended. Euro Surveill (2008) 1.66

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update (2009) 1.64

A prediction rule for elderly primary-care patients with lower respiratory tract infections. Eur Respir J (2007) 1.63

The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60

Comparative model-based analysis of screening programs for Chlamydia trachomatis infections. Am J Epidemiol (2001) 1.60

Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax (2006) 1.60

[The increase in pneumonia-related morbidity and mortality among adults in the Netherlands and possible explanations for it]. Ned Tijdschr Geneeskd (2004) 1.54

Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology (1995) 1.54

Estimation and prediction of the HIV-AIDS-epidemic under conditions of HAART using mixtures of incubation time distributions. Stat Med (2008) 1.44

Adherence to guidelines on cervical cancer screening in general practice: programme elements of successful implementation. Br J Gen Pract (2001) 1.42

Complications of standard elective abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg (1998) 1.42

Regulation of coronavirus mRNA transcription. J Virol (1995) 1.40

[Increased risk of infection in patients with diabetes mellitus type 1 or 2]. Ned Tijdschr Geneeskd (2006) 1.40

[Cost-effectiveness of influenza vaccination The Netherlands]. Ned Tijdschr Geneeskd (1997) 1.39

Screening for Coxiella burnetii infection during pregnancy: pros and cons according to the Wilson and Jungner criteria. Euro Surveill (2012) 1.39

Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis (2000) 1.37

Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncytial virus activity? Epidemiol Infect (2008) 1.25

Translation but not the encoded sequence is essential for the efficient propagation of the defective interfering RNAs of the coronavirus mouse hepatitis virus. J Virol (1995) 1.25

Characterization of an equine arteritis virus replicase mutant defective in subgenomic mRNA synthesis. J Virol (1999) 1.22

Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine? Vaccine (2009) 1.21

Major improvements in cost effectiveness of screening women for Chlamydia trachomatis using pooled urine specimens and high performance testing. Sex Transm Infect (2002) 1.18

Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect (2002) 1.16

The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity. J Virol (1997) 1.14

Diagnostic accuracy of culture-based and PCR-based detection tests for methicillin-resistant Staphylococcus aureus: a meta-analysis. Clin Microbiol Infect (2011) 1.13

Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus. J Virol (1999) 1.12

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J (2008) 1.10

[Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial]. Ned Tijdschr Geneeskd (2008) 1.08

The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis (2012) 1.08

Which determinants should be targeted to increase influenza vaccination uptake among health care workers in nursing homes? Vaccine (2009) 1.07

Modeling the effects of influenza vaccination of health care workers in hospital departments. Vaccine (2009) 1.06

Estimating influenza-related hospitalization in The Netherlands. Epidemiol Infect (1998) 1.06

Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol (2008) 1.05

Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011. Euro Surveill (2013) 1.02

Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies. J Clin Epidemiol (2008) 1.01

Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy. HIV Med (2005) 1.00

[Benefit of the serological screening program for syphilis in pregnant women in Amsterdam in the period 1985-1989]. Ned Tijdschr Geneeskd (1991) 0.99

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill (2015) 0.98

Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents (2004) 0.97

COPD in the working age population: the economic impact on both patients and government. COPD (2013) 0.97

Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients. J Clin Virol (2012) 0.97

Cost-effectiveness estimates for antenatal HIV testing in the Netherlands. Int J STD AIDS (2008) 0.96

Effects of a multi-faceted program to increase influenza vaccine uptake among health care workers in nursing homes: A cluster randomised controlled trial. Vaccine (2010) 0.96

Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia. Clin Microbiol Infect (2006) 0.92

The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa. Pharmacoeconomics (2001) 0.92

A subgenomic mRNA transcript of the coronavirus mouse hepatitis virus strain A59 defective interfering (DI) RNA is packaged when it contains the DI packaging signal. J Virol (1997) 0.92

Quantifying the potential role of unmeasured confounders: the example of influenza vaccination. Int J Epidemiol (2008) 0.91

Impact of influenza vaccination on mortality risk among the elderly. Eur Respir J (2009) 0.90

Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy (2002) 0.90

Sequences involved in the replication of coronaviruses. Adv Exp Med Biol (1987) 0.89

Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. Am J Med (2001) 0.89

Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med (1999) 0.89

Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data. Vaccine (2004) 0.89

How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review. J Antimicrob Chemother (2003) 0.88

Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program. Vaccine (2001) 0.88

Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making. Vaccine (2004) 0.87

HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations. Curr Pharm Des (2008) 0.87

Antibiotic therapy for acute Q fever in The Netherlands in 2007 and 2008 and its relation to hospitalization. Epidemiol Infect (2010) 0.87

Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Aliment Pharmacol Ther (2003) 0.86

Do general practices adhere to organizational guidelines for effective cervical cancer screening? Fam Pract (1998) 0.86

Bedside practice of blood transfusion in a large teaching hospital in Uganda: An observational study. Asian J Transfus Sci (2009) 0.86

Determination of factors required to increase uptake of influenza vaccination among hospital-based healthcare workers. J Hosp Infect (2011) 0.86

Improving population-based cervical cancer screening in general practice: effects of a national strategy. Int J Qual Health Care (1999) 0.86

Switch patterns before and after patent expiry of omeprazole: a case study in The Netherlands. Aliment Pharmacol Ther (2006) 0.86

Lifetime hospitalization profiles for symptomatic, HIV-infected persons. Health Policy (1996) 0.85

Using anticoagulation or aspirin to prevent stroke. Results of the study cannot be generalised to the general practice population. BMJ (2000) 0.85

Sequence and structure of the coronavirus peplomer protein. Adv Exp Med Biol (1987) 0.84

Clinical signs and symptoms predicting influenza infection. Arch Intern Med (2001) 0.84

Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination. Vaccine (2008) 0.84

Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands. Vaccine (2007) 0.83

Cost-effectiveness of screening for genital Chlamydia trachomatis. Expert Rev Pharmacoecon Outcomes Res (2001) 0.83

Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV-RI spike gene. Virology (1997) 0.83

Placental histopathology after Coxiella burnetii infection during pregnancy. Placenta (2011) 0.83

Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands. Vaccine (2012) 0.82

Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations. Vaccine (2009) 0.82

The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. Int J Clin Pharm (2013) 0.82

Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands. Vaccine (2009) 0.82

Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand (2013) 0.82

The significance of rhinovirus detection in hospitalized children: clinical, epidemiological and virological features. Clin Microbiol Infect (2013) 0.82

Application of guidelines on preoperative antibiotic prophylaxis in León, Nicaragua. Neth J Med (2006) 0.81

The impact of introducing patient co-payments in Germany on the use of IVF and ICSI: a price-elasticity of demand assessment. Hum Reprod (2009) 0.81

Results of aortic screening in the brothers of patients who had elective aortic aneurysm repair. Br J Surg (1998) 0.81

Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther (2003) 0.81